Cargando…

The Role of NMDA Receptor Partial Antagonist, Carbamathione, as a Therapeutic Agent for Transient Global Ischemia

Carbamathione (Carb), an NMDA glutamate receptor partial antagonist, has potent neuroprotective functions against hypoxia- or ischemia-induced neuronal injury in cell- or animal-based stroke models. We used PC-12 cell cultures as a cell-based model and bilateral carotid artery occlusion (BCAO) for s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Modi, Jigar Pravinchandra, Shen, Wen, Menzie-Suderam, Janet, Xu, Hongyuan, Lin, Chun-Hua, Tao, Rui, Prentice, Howard M., Schloss, John, Wu, Jang-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377037/ https://www.ncbi.nlm.nih.gov/pubmed/37509524 http://dx.doi.org/10.3390/biomedicines11071885

Ejemplares similares

Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model
por: Modi, Jigar, et al.
Publicado: (2020)

Sulindac for stroke treatment: neuroprotective mechanism and therapy
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2014)

Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases
por: Prentice, Howard, et al.
Publicado: (2015)

Granulocyte-colony stimulating factor gene therapy as a novel therapeutics for stroke in a mouse model
por: Menzie-Suderam, Janet M., et al.
Publicado: (2020)

Neuroprotective Mechanisms of Taurine against Ischemic Stroke
por: Menzie, Janet, et al.
Publicado: (2013)

Calpain Cleavage of Brain Glutamic Acid Decarboxylase 65 Is Pathological and Impairs GABA Neurotransmission
por: Buddhala, Chandana, et al.
Publicado: (2012)

NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013)

Effects of Transient Administration of the NMDA Receptor Antagonist MK-801 in Drosophila melanogaster Activity, Sleep, and Negative Geotaxis
por: Moulin, Thiago C., et al.
Publicado: (2023)

Allosteric antagonist action at triheteromeric NMDA receptors
por: Gibb, Alasdair J.
Publicado: (2022)

Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
por: Kang, Heather, et al.
Publicado: (2017)

Kinetic basis of partial agonism at NMDA receptors
por: Kussius, Cassandra L, et al.
Publicado: (2009)

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in Mice
por: Zheng, Chen, et al.
Publicado: (2017)

Modulation of Functional EEG Networks by the NMDA Antagonist Nitrous Oxide
por: Kuhlmann, Levin, et al.
Publicado: (2013)

NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
por: Vanle, Brigitte, et al.
Publicado: (2018)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
por: Bartsch, Caitlyn J., et al.
Publicado: (2022)

NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia
por: Savage, Sharon A., et al.
Publicado: (2019)

Intranasal Administration of Interleukin-1 Receptor Antagonist in a Transient Focal Cerebral Ischemia Rat Model
por: Lee, Jae Hoon, et al.
Publicado: (2017)

Behavioral Consequences of NMDA Antagonist-Induced Neuroapoptosis in the Infant Mouse Brain
por: Yuede, Carla M., et al.
Publicado: (2010)

NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception
por: Meuwese, Julia D. I., et al.
Publicado: (2013)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
por: Osanloo, Naser, et al.
Publicado: (2015)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury
por: Li, Yang, et al.
Publicado: (2015)

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review
por: Moore, Thomas J., et al.
Publicado: (2022)

Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities
por: Torres, Eva, et al.
Publicado: (2012)

The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice
por: Kos, Tomasz, et al.
Publicado: (2010)

Inhibition of Acetylcholinesterase Modulates NMDA Receptor Antagonist Mediated Alterations in the Developing Brain
por: Bendix, Ivo, et al.
Publicado: (2014)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: Zeiler, F. A.
Publicado: (2015)

Antioxidants as Renoprotective Agents for Ischemia during Partial Nephrectomy
por: Buys-Gonçalves, Gabriela F., et al.
Publicado: (2019)

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation
por: Shen, Le, et al.
Publicado: (2018)

Enantiopure Indolo[2,3-a]quinolizidines: Synthesis and Evaluation as NMDA Receptor Antagonists
por: Pereira, Nuno A. L., et al.
Publicado: (2016)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi
por: Santos Souza, Higo Fernando, et al.
Publicado: (2019)

NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells
por: Cyranka, Malgorzata, et al.
Publicado: (2022)

The Computer Simulation of Therapy with the NMDA Antagonist in Excitotoxic Neurodegeneration in an Alzheimer’s Disease-like Pathology
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
por: Benvenutti, Radharani, et al.
Publicado: (2022)

A Selective Histamine H(4) Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia
por: Dettori, Ilaria, et al.
Publicado: (2018)

Treatment of Cerebral Ischemia Through NMDA Receptors: Metabotropic Signaling and Future Directions
por: Li, Yuanyuan, et al.
Publicado: (2022)

The NMDA receptor partial agonist d-cycloserine does not enhance motor learning
por: Günthner, Jan, et al.
Publicado: (2016)

The Role of NMDA Receptor Antagonists in Nicotine Tolerance, Sensitization, and Physical Dependence: A Preclinical Review
por: Jain, Raka, et al.
Publicado: (2008)

Contractile properties and movement behaviour in neonatal rats with axotomy, treated with the NMDA antagonist DAP5
por: Petsanis, Konstantinos, et al.
Publicado: (2012)

A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
por: Companys-Alemany, Júlia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_19b0fjott7emjpkc0ntd02ggu4